Market Tracker

04/24 7:01am ET

Alkermes Plc (NASDAQ:ALKS)

46.77
Data as of Apr 23
 -0.29 / -0.62%
Today’s Change
26.47
Today|||52-Week Range
54.25
+15.03%
Year-to-Date

Today’s Trading

Previous close47.06
Today’s open47.23
Day’s range-- - --
Volume738,736
Average volume (3 months)1,355,170
Market cap$6.2B
Dividend yield--
Data as of 04/23/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-61.83%
Earnings growth (next 5 years)+29.43%
Revenue growth (last year)+47.59%
P/E ratio359.8
Price/Sales5.42
Price/Book6.05

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...+1.13+0.95%
SLXPSalix Pharmaceutical...+0.88+0.81%
PCYCPharmacyclics Inc+0.24+0.26%
ICPTIntercept Pharmaceut...-19.47-6.89%
Data as of 04/23/2014

Financials

Last reporting dateFebruary 27, 2014
EPS forecast (this quarter)$0.10
Annual revenue (last year)$575.5M
Annual profit (last year)$25.0M
Net profit margin4.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane Cooke
Corporate headquarters
Dublin, Dublin

Forecasts